Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant MS4A1 (Rituximab Biosimilar) antibody

This Mouse Monoclonal antibody specifically detects MS4A1 (Rituximab Biosimilar) in FACS and in vivo. It exhibits reactivity toward Human.
Catalog No. ABIN7795085

Quick Overview for Recombinant MS4A1 (Rituximab Biosimilar) antibody (ABIN7795085)

Target

MS4A1 (Rituximab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

  • 7
  • 2
  • 2
Human

Host

  • 3
  • 2
  • 1
  • 1
Mouse

Clonality

  • 4
  • 3
Monoclonal

Conjugate

  • 7
This MS4A1 (Rituximab Biosimilar) antibody is un-conjugated

Application

  • 6
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade

Research Grade
  • Expression System

    Mammalian cells

    Purpose

    Rituximab Biosimilar, Endotoxin 0.05 EU/mg

    Characteristics

    B-lymphocyte antigen CD20 encoded by the MS4A1 gene is an activated-glycosylated phosphoprotein on the surface of all B-cells. The function of the membrane protein is to stimulate B-cell immune response, specifically against T-independent antigens though its natural ligand remains unknown. CD20 is important for the development and differentiation of B-cells into plasma cells. CD20 belongs to the membrane-spanning 4A family with common structural features, similar intron/exon splice boundaries, and unique expression patterns among hematopoietic cells and nonlymphoid tissues. Rituximab, a chimeric anti-CD20 monoclonal antibody, destroys B cells and is used to treat diseases with excessive numbers of B cells, overactive B cells, or dysfunctional B cells, such as many lymphomas, leukemias, transplant rejection, and autoimmune disorders.

    Purification

    Protein A or G affinity column

    Purity

    >95 % by reducing SDS-PAGE

    Endotoxin Level

    Less than 0.5 EU/mg of protein as determined by LAL method

    Immunogen

    Human lymphoblastoid cell line SB
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    > 3 mg/mL

    Storage

    4 °C,-20 °C

    Storage Comment

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • Target

    MS4A1 (Rituximab Biosimilar)

    Alternative Name

    Rituximab Biosimilar

    Target Type

    Biosimilar
You are here:
Chat with us!